Selective CDK4 inhibition holds promise for breast cancer

Manuel Beltrán-Visiedo; Rebecca M. Shulman; Lorenzo Galluzzi

doi:10.1038/s41422-025-01117-4

Selective CDK4 inhibition holds promise for breast cancer

Manuel Beltrán-Visiedo
, Rebecca M. Shulman
, Lorenzo Galluzzi

Fox Chase Cancer Center

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Original language	English
Pages (from-to)	790-791
Number of pages	2
Journal	Cell Research
Volume	35
Issue number	11
Early online date	Apr 14 2025
DOIs	https://doi.org/10.1038/s41422-025-01117-4
State	Published - Nov 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/s41422-025-01117-4

Cite this

@article{4b9decb60a3744b49bb0ac107d320458,

title = "Selective CDK4 inhibition holds promise for breast cancer",

author = "Manuel Beltr{\'a}n-Visiedo and Shulman, \{Rebecca M.\} and Lorenzo Galluzzi",

year = "2025",

month = nov,

doi = "10.1038/s41422-025-01117-4",

language = "English",

volume = "35",

pages = "790--791",

journal = "Cell Research",

issn = "1001-0602",

publisher = "Springer Nature",

number = "11",

}

TY - JOUR

T1 - Selective CDK4 inhibition holds promise for breast cancer

AU - Beltrán-Visiedo, Manuel

AU - Shulman, Rebecca M.

AU - Galluzzi, Lorenzo

PY - 2025/11

Y1 - 2025/11

UR - https://www.scopus.com/pages/publications/105002612652

U2 - 10.1038/s41422-025-01117-4

DO - 10.1038/s41422-025-01117-4

M3 - Comment/debate

C2 - 40229555

AN - SCOPUS:105002612652

SN - 1001-0602

VL - 35

SP - 790

EP - 791

JO - Cell Research

JF - Cell Research

IS - 11

ER -

Selective CDK4 inhibition holds promise for breast cancer

UN SDGs

Access to Document

Other files and links

Cite this